In 1912, Hadassah’s first call to action was to raise enough funds to send two nurses to Palestine to treat infants and children with trachoma, a leading cause of blindness at the time. Today, the Hadassah Medical Organization (HMO) is still battling blindness with a new clinical trial that might be the cure for age-related macular degeneration (AMD).
An otherwise healthy woman had a growing blind spot at the center of her vision, joining 170 million people worldwide with AMD, according to the National Institutes of Health. While diagnosing her form of the disorder, dry AMD, was simple, there has been no effective treatment. Until now.
But today, thanks to the 15-year research effort of Dr. Eyal Banin, director of HMO’s Center for Retinal and Macular Degeneration, this otherwise healthy woman and eight others like her may be among the first in the world to have their AMD cured!
The preliminary results of this new clinical trial are exciting. HMO successes and advances like this one happen because our donors believe in us and support us. With a gift today, you will help HMO stay strong and make “360° of healing” possible by funding the modernization and improvement of the medical facilities on the Hadassah Ein Kerem campus, including the expansion of the Ophthalmology Department.